Indaptus Therapeutics, Inc. SEC filings INDP
Indaptus Therapeutics, Inc. has 343 filings in SEC EDGAR's recent list, going back to Apr 20, 2021. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 20, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 30, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 10, 2026 | Sep 8, 2026 |
| 8-K/A |
Amended current report
Material agreement
|
Sep 8, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 4, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 1, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Results of operations, Shareholder vote results
|
Aug 13, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 24, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 5, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 24, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Change in control, Officer or director change
|
Mar 24, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Change to shareholder rights, Change in control, Bylaw or fiscal year change, Shareholder vote results
|
Feb 27, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 12, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 20, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2026 | Dec 29, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
|
Dec 23, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Other events
|
Sep 4, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Unregistered share sale, Shareholder vote results
|
Jul 29, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 26, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 12, 2025 | Feb 12, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 31, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 14, 2025 | Jan 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 22, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Oct 22, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 8, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Other events
|
May 22, 2024 | May 22, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Other events
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Other events
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 23, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Other events
|
Nov 6, 2023 | Nov 4, 2023 |
| 8-K |
Current report
Other events
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Other events
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 23, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2023 | Mar 17, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 14, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 23, 2022 | Dec 22, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Sep 30, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 21, 2022 | Jul 20, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 1, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2022 | May 19, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 1, 2022 | Feb 1, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 3, 2022 | Jan 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 2, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K | Current report | Aug 16, 2021 | Aug 16, 2021 |
| 8-K/A |
Amended current report
Exit or restructuring costs, Impairment, Auditor change
|
Aug 16, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Acquisition or sale of assets, Listing notice, Unregistered share sale, Auditor change, Officer or director change, Regulation FD disclosure, Other events
|
Aug 6, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Exit or restructuring costs, Impairment, Change to shareholder rights, Change in control, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 6, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
|
Jul 29, 2021 | Jul 23, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Jul 23, 2021 | Jul 23, 2021 |
| 8-K |
Current report
Other events
|
Jul 16, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Other events
|
Jun 22, 2021 | Jun 21, 2021 |
Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INDP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1857044
- Former names
- Intec Parent Inc. (until Aug 3, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.